Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial
Year: 2023
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Authors: Bingqiong Wang, Jialing Zhou, Xiaoning Wu, Yameng Sun, Lei Li, Ping Li, Minghui Li, Wei Jiang, Mingyi Xu, Bo Feng, Xiaoyuan Xu, Jilin Cheng, Wen Xie, Tao Han, Xiaozhong Wang, Hai Li, Hongxin Piao, Xinyu Zhao, Shuyan Chen, Tongtong Meng, Qiushuang Guan, Fandong Meng, Yuanyuan Kong, Xiaojuan Ou, Jidong Jia, Hong You
Institutions: Capital Medical University, National Clinical Research Center for Digestive Diseases, Beijing Friendship Hospital, Beijing Jishuitan Hospital, Beijing YouAn Hospital, Beijing Ditan Hospital, Fudan University, Zhongshan Hospital, Shanghai Jiao Tong University, Shanghai East Hospital, Shanghai First People's Hospital, Peking University People's Hospital, Peking University First Hospital, Shanghai Public Health Clinical Center, Nankai University, Tianjin Third Central Hospital, Tianjin Medical University, Xinjiang Uygur Autonomous Region Uygur Medicine Hospital, Yanbian University, Yanbian University Hospital
Language: English
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G3396377202, G3577911001, G6092214723
OpenAlex ID: W4388422331